Concepedia
Statistics
Publications
3
Citations
82
H-Index
Active since
2020
Affiliations
National Cancer Institute(Current)
National Institutes of Health
Center for Cancer Research
Leidos (United States)
Frederick National Laboratory for Cancer Research
Michael W. Caminear is an author at National Cancer Institute specializing in cancer stem cells, molecular oncology, and medicine.
Publications per year
2020–2023
Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model
Brittney S. Harrington, Michelle Ozaki, Michael W. Caminear et al. · Cancers · 2020 · 41 citations · Full text
Medicine, Oncology, Pharmacology +17
Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells
Michael W. Caminear, Brittney S. Harrington, Rahul Kamdar et al. · Frontiers in Oncology · 2022 · 26 citations · Full text
UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer
Brittney S. Harrington, Rahul Kamdar, Franklin Ning et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 15 citations · Full text
Medicine, Molecular Biology, Oncology +17
1–3 of 3